BofA raised the firm’s price target on Wabtec to $183 from $162 and keeps a Buy rating on the shares. The firm increased its 2024 and 2025 EPS estimates 8% and 7%, respectively, and raised its multiple given Wabtec’s ramping backlog and improving margin focus.